Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Biochips Market Forecast: Value Set To Climb From $16.97 Billion To $29.03 Billion
The biochips market has experienced rapid expansion in recent years. Its size is projected to increase from $14.61 billion in 2025 to $16.97 billion in 2026, at a compound annual growth rate (CAGR) of 16.1%. The growth observed in the historic period can be attributed to factors such as the rise in genomics and proteomics research, the broadening of pharmaceutical and biotech R&D programs, the adoption of DNA microarrays in genetic screening, the increasing application of biochips in molecular diagnostics, and the development of microarray and microfluidic-based analytical platforms.
The biochips market is set to undergo significant expansion over the next few years. Its valuation is expected to reach $29.03 billion in 2030, growing at a compound annual growth rate (CAGR) of 14.4%. This anticipated growth during the forecast period is fueled by the escalating demand for precision medicine and individualized therapies, the increasing adoption of lab-on-chip technologies in clinical testing, heightened investment in biomarker discovery and translational research, the broadening applications of biochips in agriculture and life sciences, and the accelerating commercialization of advanced diagnostic tools based on biochips. Noteworthy trends predicted for this period include the rising incorporation of biochips into genetic sequencing and disease diagnostics, the expanded utilization of protein and cell arrays for sophisticated biomolecular research, an increased need for lab-on-chip platforms in point-of-care testing, the widening scope of biochip applications in drug discovery and development, and a strong focus on miniaturization combined with high-throughput biological data analysis.
Get A Free Sample Report With In-Depth Market Insights:
Biochips Market Growth Factors: What’s Supporting Expansion?
The biochips market is projected to grow significantly due to the increasing implementation of personalized medicines. Personalized medicine involves customizing medical interventions based on an individual’s specific characteristics, such as genetic profile or lifestyle, to maximize effectiveness and minimize adverse reactions. The rising demand for personalized medicine is fueled by its potential to deliver more effective therapies, advancements in genomics, the escalating complexity of diseases, and supportive regulatory frameworks. Biochips play a crucial role in personalized medicine by enabling precise and tailored treatment plans that correspond to an individual’s genetic makeup. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a notable increase from six in 2022. Thus, the growing adoption of personalized medicines is a key driver for the expansion of the biochips market.
Biochips Market Segment Landscape: Which Areas Lead Development?
The biochips market covered in this report is segmented –
1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
2) By Technology: Microarrays, Microfluidics
3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users
Subsegments:
1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays
2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays
3) By Lab-On-Chip: Microfluidic Devices, Biosensors
4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays
5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays
Biochips Market Industry Trends: What’s Reshaping Demand?
Leading firms within the biochips market are focusing on creating advanced technologies, such as organ-on-a-chip platforms, with the goal of transforming the processes of drug discovery and development. These platforms represent sophisticated microfluidic apparatuses crafted to mirror the physiological attributes and operations of human organs on a miniature scale. An example of this is seen in April 2024, when Boston Micro Fabrication (BMF), a US-based nanotechnology research firm, introduced BMF Biotechnology Inc. BMF Biotechnology Inc. focuses on Biochips, interchangeably called organ-on-a-chip platforms, which are built for growing substantial tissues in vitro. This development aids in speeding up the creation of novel pharmaceuticals and cosmetic products by offering an environment for testing and research distinct from the human body.
Biochips Market Company Landscape And Competitive Strategy
Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV
View The Full Biochips Market Report:
Biochips Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the biochips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
